1-naphthylamine has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A; Negi, G; Sharma, SS | 1 |
| Kaundal, RK; Kumar, A; Sharma, SS | 1 |
2 other study(ies) available for 1-naphthylamine and Alloxan Diabetes
| Article | Year |
|---|---|
Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; DNA Damage; Male; Metalloporphyrins; Naphthalimides; Oxidative Stress; Peripheral Nerves; Peroxynitrous Acid; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Rats; Rats, Sprague-Dawley | 2010 |
Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Male; NAD; Naphthalimides; Neural Conduction; Pain Measurement; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Sprague-Dawley; Streptozocin | 2008 |